New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants

New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants
Study presents a new SARS-CoV-2 S2 subunit vaccine that elicits strong antibody responses against various sarbecovirus strains, including challenging variants l...
In a recent study posted to the bioRxiv pre-print* server, a team of researchers developed a broadly reactive and stable severe acute respiratory syndrome coron... Read More



Related Stories

See All